Tech Company Financing Transactions

AlloCure Funding Round

AlloCure secured a $6 million funding round on 12/31/2009. Investors included SV Health Investors and private investors.

Transaction Overview

Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors

SV Health Investors (Lutz Giebel)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 Corporate Dr. 360
Burlington, MA 01803
USA
Email Address
Overview
AlloCure is focused on developing cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries.
Profile
AlloCure LinkedIn Company Profile
Social Media
AlloCure Company Twitter Account
Company News
AlloCure News
Facebook
AlloCure on Facebook
YouTube
AlloCure on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Brenner
  Robert Brenner LinkedIn Profile  Robert Brenner Twitter Account  Robert Brenner News  Robert Brenner on Facebook
Chief Operating Officer
John Wirthlin
  John Wirthlin LinkedIn Profile  John Wirthlin Twitter Account  John Wirthlin News  John Wirthlin on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2009: One Kings Lane venture capital transaction
Next: 12/31/2009: TriReme Medical venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary